Carrier Global
CARR
55.00
-1.10
-1.96%
Carrier Global
US · CARR
#483 by market cap
Listed 1970
55.00
-1.10
-1.96%
Live - 5344 symbols - heartbeat 96s ago
· 2026-10-08 05:08
Pre-market
54.81
-0.35%
After-hours
55.00
0.00%
Overnight
54.81
-0.35%
- Market cap
- 45.34B
- P/E (TTM)i
- 37.93
- P/Bi
- 3.45
- EPSi
- 1.72
- Div yieldi
- 1.69%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on CARR?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
FDA Aprova Epcoritamabe, Da AbbVie, Como Primeiro E Único Anticorpo Biespecífico Para Tratamento De Adultos Com Linfoma Difuso De Grandes Células B Recidivados/Refratários (R/R)PR Newswire · 2023/5/29
-
Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for Obecabtagene Autoleucel (Obe-cel) for Patients With Relapsed/refractory (R/r) Adult B-Cell Acute Lymphoblastic Leukemia (ALL)GlobeNewswire · 2023/11/27
-
Richtech Robotics (RR): Reassessing an 8x Book Valuation After U.S. Robotics Policy Tailwinds and AI PartnershipsYahoo Finance · 2025/12/5
-
BeOne Medicines' BEQALZI (Sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell LymphomaYahoo Finance · 2026/5/14
-
Company notice
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - U.S. FDA GRANTED BREAKTHROUGH THERAPY DESIGNATION TO ANTI-PD-L1 ANTIBODY SUGEMALIMAB FOR THE TREATMENT OF ADULT PATIENTS WITH R/R ENKTLHKEX · 2020/10/23
-
U.S. Stock Market Movement | Robotics Concept Stocks Strengthen as Richtech Robotics (RR.US) Surges Over 15%Zhitong Finance · 2025/10/3
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 05:08:59 · For reference only, not investment advice and not tailored to your situation.